XERS Xeris Biopharma Holdings, Inc.

NASDAQ
$8.70

Xeris Biopharma Holdings, Inc. (XERS) Institutional Ownership

What the institutions did with XERS last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
261
filed a 13F this quarter
Managers holding
233
+2 on the quarter
Buyers
135
30 opened new
Sellers
93
28 sold out entirely
Buyer share
59.2%
of managers who traded it
Breadth
+18.4
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
BlackRock, Inc. 14.5M 13.4%
D. E. Shaw & Co., Inc. 7.8M 7.2%
VANGUARD CAPITAL MANAGEMENT LLC 7.3M 6.8%
STATE STREET CORP 4.8M 4.5%
GEODE CAPITAL MANAGEMENT, LLC 4.7M 4.4%
Nuveen, LLC 4.4M 4.1%
Rosalind Advisors, Inc. 2.9M 2.7%
Qube Research & Technologies Ltd 2.9M 2.7%
VANGUARD PORTFOLIO MANAGEMENT LLC 2.6M 2.4%
WELLINGTON MANAGEMENT GROUP LLP 2.4M 2.2%
MORGAN STANLEY 2.3M 2.2%
Legal & General Group Plc 2.0M 1.9%
ARMISTICE CAPITAL, LLC 2.0M 1.8%
TWO SIGMA INVESTMENTS, LP 1.9M 1.7%
Parkman Healthcare Partners LLC 1.8M 1.7%
ALGERT GLOBAL LLC 1.7M 1.6%
NORTHERN TRUST CORP 1.6M 1.5%
GOLDMAN SACHS GROUP INC 1.6M 1.5%
AQR CAPITAL MANAGEMENT LLC 1.5M 1.4%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5M 1.4%
FEDERATED HERMES, INC. 1.4M 1.3%
BANK OF AMERICA CORP /DE/ 1.4M 1.3%
UBS Group AG 1.3M 1.2%
Ishara Investments LP 1.2M 1.1%
VANGUARD FIDUCIARY TRUST CO 1.2M 1.1%

Largest changes

Manager Action Previous Current Change
MILLENNIUM MANAGEMENT LLC Reduced 2.3M 131.7K -2.1M
BlackRock, Inc. Increased 12.9M 14.5M +1.6M
Nuveen, LLC Increased 2.9M 4.4M +1.5M
Voss Capital, LP Sold Out 1.4M 0 -1.4M
Qube Research & Technologies Ltd Reduced 4.1M 2.9M -1.2M
DIMENSIONAL FUND ADVISORS LP New 0 1.1M +1.1M
CenterBook Partners LP Reduced 1.2M 280.6K -968.1K
Driehaus Capital Management LLC Sold Out 902.7K 0 -902.7K
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Increased 133.8K 972.9K +839.1K
JANE STREET GROUP, LLC Reduced 725.6K 61.9K -663.7K
Walleye Capital LLC New 0 611.3K +611.3K
ALGERT GLOBAL LLC Increased 1.2M 1.7M +586.0K
FEDERATED HERMES, INC. Increased 856.8K 1.4M +577.6K
BANK OF AMERICA CORP /DE/ Increased 874.4K 1.4M +522.7K
Trexquant Investment LP Reduced 833.2K 339.1K -494.1K
FIRST TRUST ADVISORS LP New 0 485.0K +485.0K
PERCEPTIVE ADVISORS LLC New 0 467.0K +467.0K
JPMORGAN CHASE & CO Increased 612.5K 1.1M +445.6K
GEODE CAPITAL MANAGEMENT, LLC Increased 4.3M 4.7M +427.6K
RENAISSANCE TECHNOLOGIES LLC Reduced 452.9K 67.3K -385.5K
VOLORIDGE INVESTMENT MANAGEMENT, LLC Sold Out 370.1K 0 -370.1K
VANGUARD CAPITAL MANAGEMENT LLC Increased 7.0M 7.3M +359.3K
UBS Group AG Reduced 1.6M 1.3M -345.5K
Rosalind Advisors, Inc. Reduced 3.2M 2.9M -322.7K
Connor, Clark & Lunn Investment Management Ltd. Reduced 407.6K 127.1K -280.5K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.